EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -50.0% | 23 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | – | 23 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MMCAP International Inc. SPC | 145,941 | $18,856 | 0.00% |
| ARISTEIA CAPITAL, L.L.C. | 1,540,297 | $153,106 | 0.00% |
| Sea Otter Advisors LLC | 25,000 | $3,230 | 0.00% |
| LITTLEJOHN & CO LLC | 16,666 | $2,153 | 0.00% |
| WHITEBOX ADVISORS LLC | 298,145 | $38,520 | 0.00% |
| Citadel Advisors | 27,743 | $3,584 | 0.00% |
| III Capital Management | 41,795 | $4,154 | 0.00% |
| Tower Research Capital LLC (TRC) | 23 | $0 | 0.00% |
| Parallel Advisors, LLC | 64,166 | $4,812 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |